Browse drugs

…and a non-vitamin K antagonist OAC. In this patient population, clopidogrel is the P2Y12 inhibitor of choice given the significantly lower …

…receptor targeted agents (ARTAs) used to treat prostate cancer, enzalutamide1 is a valid option at several stages of the disease. In terms of…

…lowing this diagnosis, the patient started anticoagulation with rivaroxaban. However, after 2 months of anticoagulation, she reported no im…

…ximum 32 mg/day) was started together with supportive measures. Bromocriptine was later added to cover potential diagnostic overlap.Results O…

…ents with atrial fibrillation who were treated with apixaban or rivaroxaban between October 2020 and May 2022. Patients were categorised ba…

…coagulation, transitioning from low-molecular-weight heparin to rivaroxaban, with complete recovery.…

…an or rivaroxaban) are commonly prescribed for this indication. Dabigatran, an oral direct thrombin inhibitor, is similarly approved. In v…

… fistulation. This patient was managed with a 6-month course of rivaroxaban. After completing 2 weeks of intravenous meropenem, he was conv…

…invasion of the left pulmonary artery. Her medications included cilostazol (200 mg/day) and prednisolone (5 mg/day). Physical examination …

…rial trunk. Upon these findings, therapy with the anticoagulant rivaroxaban was immediately initiated. Despite a partial reduction in the D…

…ic etiology was scheduled for urgent robotic repair. She was on rivaroxaban preoperatively. Total intravenous anesthesia was performed usin…

…llowing 72-hours of observation, she was discharged with 5-days LMWH 100 units/kg BD then switched to oral rivaroxaban 5 mg BD for 3…